Lung cancer: district active treatment rates affect survival

Lung cancer: district active treatment rates affect survival.

STUDY OBJECTIVE This study investigates variation in management and treatment of lung cancer patients and determines the impact of any variation in treatment on survival. DESIGN A retrospective study of population based data held by the Northern & Yorkshire Cancer Registry and Information Service (NYCRIS), comparing active treatment rates for lung cancer with survival by districts. SETTING Th...

PUBLIC HEALTH POLICY AND PRACTICE Lung cancer: district active treatment rates affect survival

M L Cartman, A C Hatfield, M F Muers, M D Peake, R A Haward, D Forman on behalf of the Yorkshire Cancer Management Study Group, Northern and Yorkshire Cancer Registry and Information Service, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

Active treatment rates for lung cancer in south Manchester: are we doing enough?

In an effort to improve the current lung cancer treatment outcomes in Britain, National guidelines were published followed by the introduction of National Lung Cancer Audit (LUCADA) project. LUCADA has defined active treatment as any therapeutic intervention with the aim of improving the quality or length of patients' survival irrespective of whether it is curative or palliative. From August 20...

Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry

  Background:The present study compared the differences between survivals of patients with colorectal cancer according to their ethnicity adjusted for other predictors of survival.   Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal cancer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients on...

Interpreting cancer survival rates.